RK Pharma Inc

About RK Pharma Inc

RK Pharma Inc is a privately held US-based company focused on the development, manufacturing, and commercialization of high-quality and affordable generic pharmaceutical products worldwide. Established with the vision of contributing to the healthcare industry, the company emphasizes integrated development, regulatory, and manufacturing capabilities.

Products & Services

Generic Pharmaceutical Products: High-quality and affordable generic drugs with a focus on formulation challenges and first generic opportunities.

Injectables, Sterile Ophthalmic, and Dermal Products: Manufactured at their state-of-the-art facility in Pearl River, NY.

Solid Oral Dosage Forms: Currently manufactured through partner companies.

Specialties

Generic pharmaceutical development Manufacturing of injectables, sterile ophthalmic, and dermal products Formulation challenges First generic opportunities

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Equity T: - FT: Private Equity	A: 200000000 MR: - FA: up to 200 million USD FAN: 200000000	D: 2023-06-06 FD: 2023-06-06	1 investors

Private Equity Latest

2023-06-06

$200.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Ravishanker Kovi

Executive Chairman & Director

G

George R. Thomas

President & CEO, Director

M

Muralikrishna Madala

Director

J

Jayaraman Kannapan

President - Apicore India

N

Naveen Paladugu

COO, Director

N

Nailesh Bhatt

CEO, VGYAAN Pharmaceuticals

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

RK Pharma Inc Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised